Skip to Content

UK Edition. Click here for US version.

PLENDIL 5MG

Active substance(s): FELODIPINE

View full screen / Print PDF » Download PDF ⇩
Transcript
P042053

Package leaflet: Information for the patient

Plendil 2.5 mg prolonged-release tablets
Plendil 5 mg prolonged-release tablets
Plendil 10 mg prolonged-release tablets

felodipine
Read all of this leaflet carefully before you start taking this medicine because it
contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor. This includes any possible side effects not
listed in this leaflet. See section 4.
What is in this leaflet
1. What Plendil is and what it is used for
2. What you need to know before you take Plendil
3. How to take Plendil
4. Possible side effects
5. How to store Plendil
6. Contents of the pack and other information
1. What Plendil is and what it is used for
Plendil contains the active substance felodipine. This belongs to a group of medicines called
calcium antagonists. It lowers blood pressure by dilating small blood vessels. It does not
negatively affect the heart function.
Plendil is used in the treatment of high blood pressure (hypertension) and heart and chest
pain brought on by for example exercise or stress (angina pectoris).
2. What you need to know before you take Plendil
Do not take Plendil
• if you are pregnant. You should tell your doctor as soon as possible if you become
pregnant while using this medicine.
• if you are allergic to felodipine or any of the other ingredients of this medicine (listed in section 6).
• if you suffer from uncompensated heart failure.
• if you have acute myocardial infarction (heart attack).
• if you have chest pain of recent onset, or angina pectoris that is lasting for more than
15 minutes or longer or is more severe than usual.
• if you have disease of a heart valve or heart muscle, until you have talked to your doctor.
Warnings and precautions
Plendil, like other blood-pressure lowering medicinal products, may in rare cases lead to
pronounced low blood pressure which in some patients may result in an inadequate supply
of blood to the heart. Symptoms of excessive low blood pressure and inadequate blood
supply to the heart itself, frequently include dizziness and chest pain. If you experience these
symptoms, seek emergency care immediately.
Talk to your doctor before taking Plendil, especially if you have problems with your liver.
Taking Plendil may cause your gums to become swollen. Practice good oral hygiene to help
avoid your gums from swelling (see section 4).
Children
The use of Plendil is not recommended in children.
Other medicines and Plendil
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Some medicines/herbal remedies can affect treatment with Plendil.
Examples are:
• cimetidine (medicine to treat gastric ulcers)
• erythromycin (medicine to treat infections)
• itraconazole (medicine to treat fungi)
• ketoconazole (medicine to treat fungi)
• medicines to treat HIV protease inhibitors (such as ritonavir)
• medicines to treat HIV infection (such as efavirenz, nevirapine)
• phenytoin (medicine to treat epilepsy)
• carbamazepine (medicine to treat epilepsy)
• rifampicin (medicine to treat infections)
• barbiturates (medicine to treat anxiety, sleeping problems and epilepsy)
• tacrolimus (medicine used in organ transplantations)
Medicines containing St John’s wort (Hypericum perforatum) (herbal product used to treat
depression) may reduce the effect of Plendil and should therefore be avoided.
Plendil with food and drink
Do not drink grapefruit juice if you are treated with Plendil, as this may increase the effect of
Plendil and the risk of side effects.
Pregnancy and breast-feeding
Pregnancy
Do not use Plendil if you are pregnant.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. Plendil is not
recommended for mothers who are breast-feeding, and your doctor may choose another
treatment for you if you wish to breast-feed.
Driving and using machines
Plendil can have minor or moderate influence on your ability to drive and use machines. If
you experience headache, nausea, dizziness or fatigue your ability to react may be impaired.
Caution is recommended especially at the start of treatment.
Plendil contains lactose and castor oil
Plendil contains lactose that is a type of sugar. If you have been told by your doctor that you
have intolerance to some sugars, contact your doctor before taking this medicine.
Plendil contains castor oil, which may cause stomach upset and diarrhoea.
3. How to take Plendil
Always take this medicine exactly as your doctor has told you. Check with your doctor if you
are not sure.
Plendil extended release tablets should be taken in the morning and be swallowed with water.
The tablet must not be divided, crushed or chewed. This medicine can be taken without food
or following a light meal not high in fat or carbohydrates.
Hypertension
Treatment should be started with 5 mg once a day. If necessary, your doctor may increase
the dose or add another blood-pressure lowering medicine. The usual dose when treating this
disease for a long time is 5‑10 mg once a day. In elderly patients, a starting dose of 2.5 mg daily
may be considered.
Stable angina pectoris
Treatment should be started with 5 mg once a day and if needed, your doctor may increase
the dose to 10 mg once a day.
If you have liver problems
The level of felodipine in your blood may be increased. Your doctor may lower the dose.
Elderly people
Your doctor may initiate treatment with the lowest available dose.
If you take more Plendil than you should
If you take more than the recommended number of doses of Plendil, you may suffer from very
low blood pressure and sometimes palpitations, high or, rarely, slow heart rate. Therefore, it is
very important that you take the number of doses prescribed by your doctor. If you experience
symptoms such as feeling faint, light-headedness or dizziness, contact your doctor immediately.
If you forget to take Plendil
If you forget to take a tablet, leave out that dose completely. Take your next dose at the
right time. Do not take a double dose to make up for a forgotten dose.
If you stop taking Plendil
If you stop taking this medicine your condition may return. Please consult your doctor and seek
advice before you stop taking Plendil. Your doctor will advise you how long to take your medicine.
If you have any further questions on the use of this medicine, ask your doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of the following happen to you, stop taking Plendil and tell a doctor straight away:
• Hypersensitivity and allergic reactions: The signs may include raised lumps on your skin
(weals) or swelling of your face, lips, mouth, tongue or throat.
The following undesirable effects have been identified. Most of these reactions appear at
start of treatment or after a dose increase. Should such reactions occur, they are usually brief
and diminish in intensity with time. If you experience any of the following symptoms and they
persist, please tell your doctor.
Mild enlargement of the gums has been reported in patients with an inflammation in the mouth
(gingivitis/periodontitis). The enlargement can be avoided or reversed by careful oral hygiene.
Very common: may affect more than 1 in 10 people
• Ankle swelling

Area for text

Common: may affect up to 1 in 10 people
• Headache
• Flushing
Uncommon: may affect up to 1 in 100 people
• Abnormally rapid heart rate
• Palpitations
• Too low blood pressure (hypotension)
• Nausea
• Abdominal pain
• Burning/prickling/numbness
• Rash or itching
• Fatigue
• Dizziness
Rare: may affect up to 1 in 1,000 people
• Fainting
• Vomiting
• Nettle rash
• Pain in joints
• Muscular pain
• Impotence/sexual dysfunction
Very rare: may affect up to 1 in 10,000 people
• Gingivitis (swollen gums)
• Increased liver enzymes
• Skin reactions due to increased sensitivity to sunlight
• Inflammation of small blood vessels of the skin
• A need to pass water frequently.
• Hypersensitivity reactions such as fever or swelling of the lips and tongue
Other undesirable effects may occur. If you have any bothersome or unusual reaction while
taking Plendil, check with your doctor right away.
Reporting of side effects
If you get any side effects, talk to your doctor. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme.
Website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more
information on the safety of this medicine.
5. How to store Plendil
This medicine does not require any special storage conditions.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, blister and bottle
after ‘EXP’. The expiry date refers to the last day of that month.
Do not use this medicine if you notice the packaging is torn or damaged.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how
to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Plendil contains
• The active substance is felodipine. Each tablet contains 2.5 mg (or 5 mg or 10 mg) of felodipine.
• The other ingredients are:
Tablet core:
Hydroxypropylcellulose
Hypromellose 50 mPa·s
Hypromellose 10000 mPa·s
Lactose anhydrous
Macrogolglycerol hydroxystearate
Microcrystalline cellulose
Propyl gallate
Sodium aluminium silicate
Sodium stearyl fumarate
Tablet coating:
Carnauba wax
Iron oxide reddish-brown (E172) (Only used for Plendil 5 mg and 10 mg)
Iron oxide yellow (E172)
Hypromellose 6 mPa·s
Macrogol 6000
Titanium dioxide (E171)
What Plendil looks like and contents of the pack
Plendil 2.5 mg prolonged-release tablet is yellow, circular, biconvex, engraved A/FL on one
side and 2.5 on the other side, with a diameter of 8.5 mm.
Plendil 5 mg prolonged-release tablet is pink, circular, biconvex, engraved A/Fm on one side
and 5 on the other side, with a diameter of 9 mm.
Plendil 10 mg prolonged-release tablet is reddish-brown, circular, biconvex, engraved A/FE
on one side and 10 on the other side, with a diameter of 9 mm.
Pack sizes prolonged-release tablets 2.5 mg
20 tablets (blister pack)
28 tablets (blister pack with days of the week printed)
30 tablets (blister pack and plastic bottle)
50 tablets (unit-dose pack)
98 tablets (blister pack with days of the week printed)
100 tablets (blister pack and plastic bottle)
500 tablets (plastic bottle for dose dispensing)
Pack sizes prolonged-release tablets 5 mg
14 tablets (blister pack with days of the week printed)
20 tablets (blister pack)
28 tablets (blister pack with days of the week printed)
30 tablets (blister pack and plastic bottle)
50 tablets (unit-dose pack)
90 tablets (blister pack)
98 tablets (blister pack with days of the week printed)
100 tablets (blister pack and plastic bottle)
500 tablets (plastic bottle for dose dispensing)
Pack sizes prolonged-release tablets 10 mg
14 tablets (blister pack with days of the week printed)
20 tablets (blister pack)
28 tablets (blister pack with days of the week printed)
30 tablets (blister pack and plastic bottle)
50 tablets (unit-dose pack)
90 tablets (blister pack)
98 tablets (blister pack with days of the week printed)
100 tablets (blister pack, plastic bottle and plastic bottle for dose dispensing)
500 tablets (plastic bottle for dose dispensing)
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
The Marketing Authorisation for Plendil is held by:
AstraZeneca UK Limited
600 Capability Green
Luton
LU1 3LU
UK
Plendil is manufactured by:
AstraZeneca UK Limited
Silk Road Business Park
Macclesfield
Cheshire
SK10 2NA
UK
This medicinal product is authorised in the Member States of the EEA under the
following names:
Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland,
Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands,
Norway, Poland, Romania, Slovakia, Spain, Sweden, United Kingdom: Plendil
France: Flodil
Germany: Modip
Portugal: Preslow

To listen to or request a copy of this leaflet in Braille, large
print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name
Reference number
Plendil 2.5 mg tablets
17901/0156
Plendil 5 mg tablets
17901/0157
Plendil 10 mg tablets
17901/0155
This is a service provided by the Royal National Institute
of the Blind.
This leaflet was last revised in August 2016.
© AstraZeneca 2016
Plendil is a trade mark of the AstraZeneca group of companies.
CV 16 0045

P042053

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide